CASSIE DE LOS ANGELES: Open Payments
NPI 1831678572 · OVIEDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 73 payments from 19 companies in 2025. Trend: 2023 $315 · 2024 $267 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $379 |
| UCB, Inc. | 6 | $166 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $155 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Janssen Biotech, Inc. | 11 | $144 |
| GENZYME CORPORATION | 3 | $68 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Amgen Inc. | 2 | $51 |
| Incyte Corporation | 2 | $40 |
Products named: SKYRIZI, Bimzelx, DAXI, TREMFYA, RINVOQ, DUPIXENT, ACTHAR, COSENTYX.
Industry payments across FL — which companies pay providers there.
